These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 1972791
1. Downregulation of the early genomic growth factor response in neu oncogene-transformed cells. Sistonen L, Koskinen PJ, Lehväslaiho H, Lehtola L, Bravo R, Alitalo K. Oncogene; 1990 Jun; 5(6):815-21. PubMed ID: 1972791 [Abstract] [Full Text] [Related]
2. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation. Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K. J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346 [Abstract] [Full Text] [Related]
3. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H. Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145 [Abstract] [Full Text] [Related]
4. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase. Lehväslaiho H, Sistonen L, diRenzo F, Partanen J, Comoglio P, Hölttä E, Alitalo K. J Cell Biochem; 1990 Mar; 42(3):123-33. PubMed ID: 1969420 [Abstract] [Full Text] [Related]
5. Similar early gene responses to ligand-activated EGFR and neu tyrosine kinases in NIH3T3 cells. Koskinen P, Lehväslaiho H, MacDonald-Bravo H, Alitalo K, Bravo R. Oncogene; 1990 Apr; 5(4):615-8. PubMed ID: 1970155 [Abstract] [Full Text] [Related]
6. ras and neu oncogenes reverse serum inhibition and epidermal growth factor dependence of serum-free mouse embryo cells. Shirahata S, Rawson C, Loo D, Chang YJ, Barnes D. J Cell Physiol; 1990 Jul; 144(1):69-76. PubMed ID: 1973170 [Abstract] [Full Text] [Related]
7. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Ram TG, Ethier SP. Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665 [Abstract] [Full Text] [Related]
9. Activation of an EGFR/neu chimeric receptor: early intracellular signals and cell proliferation responses. Pandiella A, Lehvaslaiho H, Magni M, Alitalo K, Meldolesi J. Oncogene; 1989 Nov; 4(11):1299-305. PubMed ID: 2573029 [Abstract] [Full Text] [Related]
10. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH. EMBO J; 1997 Sep 15; 16(18):5608-17. PubMed ID: 9312020 [Abstract] [Full Text] [Related]
11. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation. Donato NJ, Ince C, Rosenblum MG, Gallick GE. J Cell Biochem; 1989 Nov 15; 41(3):139-57. PubMed ID: 2482293 [Abstract] [Full Text] [Related]
12. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells. Zhao J, Buick RN. Cancer Res; 1995 Dec 15; 55(24):6181-8. PubMed ID: 8521411 [Abstract] [Full Text] [Related]
13. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1. Ito E, Sweterlitsch LA, Tran PB, Rauscher FJ, Narayanan R. Oncogene; 1990 Dec 15; 5(12):1755-60. PubMed ID: 2178237 [Abstract] [Full Text] [Related]
14. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI. Oncogene; 1994 Aug 15; 9(8):2109-23. PubMed ID: 7913542 [Abstract] [Full Text] [Related]
15. The role of the neu oncogene product in cell transformation and normal development. Kokai Y, Wada T, Myers JN, Brown VI, Dobashi K, Cohen J, Hamuro J, Weiner DB, Greene MI. Princess Takamatsu Symp; 1988 Aug 15; 19():45-57. PubMed ID: 2908355 [Abstract] [Full Text] [Related]
16. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Weiner DB, Liu J, Cohen JA, Williams WV, Greene MI. Nature; 1989 May 18; 339(6221):230-1. PubMed ID: 2654648 [Abstract] [Full Text] [Related]
17. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. Maity A, Pore N, Lee J, Solomon D, O'Rourke DM. Cancer Res; 2000 Oct 15; 60(20):5879-86. PubMed ID: 11059786 [Abstract] [Full Text] [Related]
18. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Tuck AB, Hota C, Wilson SM, Chambers AF. Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946 [Abstract] [Full Text] [Related]
19. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities. Liu SM, Carpenter G. J Cell Physiol; 1993 Nov 27; 157(2):237-42. PubMed ID: 7901224 [Abstract] [Full Text] [Related]
20. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells. Izumi H, Ono M, Ushiro S, Kohno K, Kung HF, Kuwano M. Exp Cell Res; 1994 Oct 27; 214(2):654-62. PubMed ID: 7523156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]